Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Finkelstein

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Business and Health|August 6, 1995
Calculating the workplace cost of chronic diseaseP E Greenberg, S N Finkelstein, E R Berndt
Journal of Dental Education|November 1, 1989
Factors associated with clinical dental faculty research productivityJ E Jones, G C Preusz, S N Finkelstein
Journal of Health Care Technology|March 6, 1985
The process of evaluating medical technologies for third-party coverageS N Finkelstein, K A Isaacson, J J Frishkopf
Journal of Occupational and Environmental Medicine|November 26, 1999
Loss of work productivity due to illness and medical treatmentI M Cockburn, H L Bailit, E R Berndt, et al.
Journal of Occupational and Environmental Medicine|January 12, 2005
Performance decrements resulting from illness in the workplace: the effect of headachesG S Pransky, E Berndt, S N Finkelstein, et al.
Business and Health|July 1, 1999
When antihistamines go to workI M Cockburn, H L Bailit, E R Berndt, et al.
The Journal of Clinical Psychiatry|November 1, 1993
The economic burden of depression in 1990P E Greenberg, L E Stiglin, S N Finkelstein, et al.
The Journal of Clinical Psychiatry|November 1, 1993
Depression: a neglected major illnessP E Greenberg, L E Stiglin, S N Finkelstein, et al.
International Journal of Clinical Practice|August 9, 2002
Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxietyG J Wan, W H Crown, E R Berndt, et al.
Pharmacoeconomics|February 8, 2000
Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemiaP Y Cremieux, S N Finkelstein, E R Berndt, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Business and Health|August 6, 1995
Calculating the workplace cost of chronic diseaseP E Greenberg, S N Finkelstein, E R Berndt
Journal of Dental Education|November 1, 1989
Factors associated with clinical dental faculty research productivityJ E Jones, G C Preusz, S N Finkelstein
Journal of Health Care Technology|March 6, 1985
The process of evaluating medical technologies for third-party coverageS N Finkelstein, K A Isaacson, J J Frishkopf
Journal of Occupational and Environmental Medicine|November 26, 1999
Loss of work productivity due to illness and medical treatmentI M Cockburn, H L Bailit, E R Berndt, et al.
Journal of Occupational and Environmental Medicine|January 12, 2005
Performance decrements resulting from illness in the workplace: the effect of headachesG S Pransky, E Berndt, S N Finkelstein, et al.
Business and Health|July 1, 1999
When antihistamines go to workI M Cockburn, H L Bailit, E R Berndt, et al.
The Journal of Clinical Psychiatry|November 1, 1993
The economic burden of depression in 1990P E Greenberg, L E Stiglin, S N Finkelstein, et al.
The Journal of Clinical Psychiatry|November 1, 1993
Depression: a neglected major illnessP E Greenberg, L E Stiglin, S N Finkelstein, et al.
International Journal of Clinical Practice|August 9, 2002
Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxietyG J Wan, W H Crown, E R Berndt, et al.
Pharmacoeconomics|February 8, 2000
Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemiaP Y Cremieux, S N Finkelstein, E R Berndt, et al.
Pageof 3